Prostate cancer: where are we and where are we going?

Br J Urol. 1997 Mar:79 Suppl 1:2-7. doi: 10.1111/j.1464-410x.1997.tb00794.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Health Care Costs
  • Humans
  • Male
  • Mass Screening
  • Neoplasm Metastasis
  • Prostatic Neoplasms* / diagnosis
  • Prostatic Neoplasms* / economics
  • Prostatic Neoplasms* / therapy

Substances

  • Androgen Antagonists